Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666156 | SCV000790401 | pathogenic | Muscle eye brain disease | 2017-05-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001861750 | SCV002247294 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2O; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3 | 2022-07-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 551169). This premature translational stop signal has been observed in individual(s) with POMGNT1-related conditions (PMID: 20816175, 22323514). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser153*) in the POMGNT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POMGNT1 are known to be pathogenic (PMID: 19299310, 20816175, 21447391, 26908613, 27391550). |
Baylor Genetics | RCV003465446 | SCV004206024 | pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 | 2022-07-21 | criteria provided, single submitter | clinical testing |